Agilent Technologies Inc vs Stanley Black & Decker, Inc. — how do they compare? Agilent Technologies Inc trades at $149.48 (market cap $42.00B), while Stanley Black & Decker, Inc. trades at $104.33 (market cap $15.50B). The key difference: Agilent Technologies Inc is far larger — about 2.7× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.27%). Which is the better fit depends on your goals.
| A | SWK | |
|---|---|---|
Market Cap | $42.00B | $15.50B |
Sector | Health | — |
52-Week High | $157.20 | $103.89 |
52-Week Low | $110.24 | $62.12 |
Enterprise Value | $43.55B | $19.67B |
Dividend Yield | 0.69% | 3.27% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Stanley Black & Decker (SWK) trades at $103.89, up 2.82% today, showing strong momentum after recent earnings beats. The stock demonstrates improving fundamentals with Q2 2026 EPS of $1.57 beating estimates by 30%, while technical indicators show bullish moving averages but overbought RSI levels. Recent corporate developments include debt reduction of $1.7 billion and a dividend increase to $0.84 per share.
SWK presents a mixed outlook with strong operational improvements and margin expansion offset by valuation concerns. The stock trades above analyst consensus target of $93.67, suggesting limited near-term upside. Key opportunities include continued margin recovery and market share gains, while risks involve economic sensitivity and competitive pressures in the tools industry.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →